Trial Details

COMPLETED
Basic Information
Clinical ID c1434
Identifier NCT05045768
Trial Title Postinfectious Irritable Bowel Syndrome and Gelsectan
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome
Interventions DRUG: (Gelsectan, Devintec Sagl)
Participant Information
Sponsor Evangelismos Hospital
City Attica
Country/Region Greece
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2021-09-01
Primary Completion Date 2024-02-26
Completion Date 2024-02-26